"Dzhakavi" (ruksolitinib) farashin takwarorinsu. Ina saya mai rahusa Dzhakavi

A sabon maganin "Dzhakavi" kerarre ta Swiss kamfanin "Novartis" ne mashahuri a cikin likitoci suka yi wa ciwon daji.

Ruksolitinib, babban aiki sashi na Said yana nufin - mai gina jiki tyrosine kinase hanawa. Yana da tasiri a lura da cututtuka waxanda ake dangantawa da splenomegaly, myelofibrosis kazalika (ciki har da firamare da sakandare, wanda ci gaba a sakamakon da muhimmanci thrombocythemia da polycythemia).

Da masu bincike lura cewa yin amfani da miyagun ƙwayoyi rage baƙin ciki size da 35%, ta ƙara rayuwa da kuma inganci. Kamar wancan ne da yawan guba na aiki sashi ne matsakaici idan aka kwatanta da sauran kwayoyi da irin wannan bakan da aikin.

Inda za ka iya "Dzhakavi" kwayoyi saya mai rahusa

Amma kafin a ci gaba da bayanin da miyagun ƙwayoyi, ba za mu iya ce game da magani daga tsanani cututtuka na bukatar mai yawa tsada da kwayoyi, da kuma wannan ba zai iya amma sa damuwa tsakanin marasa lafiya. Bari muhimmanci magunguna ne ba zai yiwu, amma kuma don samun su ne sau da yawa quite wuya. Saboda haka, a cikin drugstores na Moscow a kan kwaya "Dzhakavi 'farashin farawa daga 100 000 rubles.

Don ceto a cikin wannan halin da ake ciki zai iya zo WWW.ONKO24.COM site inda za ka iya saya a Generic magani da ake kira. Lokacin da kama ne cikakke, kuma wannan sakamako a kan aikace-aikacen da shi za kudin da yawa mai rahusa. Gaskiyar cewa Generic samarwa ba ya kai kudin tasowa, gwaji, da kuma gabatarwa kayan aikin da damar ta masana'antun aiki a karkashin hukuma lasisi, biya mayar da saki da miyagun ƙwayoyi a ƙananan kudin.

Dosing da kashi shiri

Marasa lafiya ya kamata sane da cewa yin amfani da "Dzhakavi" da miyagun ƙwayoyi ne m abinci ci. Kuma idan a iddarsu ga wani abin sha kasa kwamfutar hannu, ba za ka iya daukar wani biyu kashi na su. Ba lallai ba ne saboda wannan motsi da kuma na gaba liyafar.

A farko kashi na bayyana kayayyakin an wajabta kawai da wani gwani, dangane da sigogi na jini - platelet count. Yawancin lokaci, shi ne 15 MG (p Take 2 a kowace rana.), Ciki har da a 100-200 / NL, yayin da wani adadin fiye da 200 / NL - 20 MG. Idan yawan platelets ne 50-100 / NL, matsakaicin farko kashi kada wuce 5 MG sau biyu a rana. A kalla kashi zai da'awar annexed miyagun kwayoyi "Dzhakavi" umarnin don amfani kada wuce 25 MG, dauka kullum sau biyu.

Kullum, da magani ya kamata a da za'ayi a kai a kai ruksolitinibom count a maikacin jini (erythrocytes, leukocytes da platelets) kowane 2-4 makonni a lokacin selection na da kashi sa'an nan, dangane da asibiti alamomi.

contraindications

Domin yin amfani da miyagun ƙwayoyi "Dzhakavi" akwai wasu contraindications:

1. Pregnancy kuma lactation.
2. Haƙuri shekaru matasa, fiye da shekara goma sha takwas da haihuwa.
3. Personal ruksolitiniba rashin ha} uri ko wasu bangaren na cikin shirye-shiryen.

Kamar yadda ya bayyana a cikin aikace-aikace na data kasance "Dzhakavi" martani na masana, yana nufin bukatar da za a yi amfani da hankali da magani na marasa lafiya da na koda gazawar ko hemodialysis. A cikin wannan rukunin da kuma hada marasa lafiya da thrombocytopenia, neutropenia da anemia.

illa

A cikin aikace-aikace, kamar yadda aka nuna a haɗe zuwa "Dzhakavi" wa'azi, mafi sau da yawa kiyaye wadannan m halayen:

• urinary fili cututtuka.
• anemia.
• neutrophils.
• thrombocytopenia.
• zub da jini (ciki har da bruising, hanci da kuma intracranial zub da jini da kuma hemorrhage a cikin gastrointestinal fili).
• nauyi riba.
• dizziness.
• hypercholesterolemia.
• ciwon kai.